New Jersey-based Catalent Biologics has completed the expansion of two new suites at its biologics drug substance development and manufacturing facility in Madison, according to a report from Contract Pharma. The expansion has more than doubled the overall biomanufacturing capacity, increasing the number of manufacturing suites at the site to five.
Related story: Catalent Biologics to expand in Madison
